Lead compounds discovered from libraries

Current Opinion in Chemical Biology

Volumn 5, Issue 3, 2001, Pages 273-284

  Golebiowski, Adam ^a   Klopfenstein, Sean R ^a   Portlock, David E ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [1 [3 (4 PIPERIDINYL)PROPIONYL]NIPECOTOYLAMINO] 3 (3 PYRIDYL)PROPIONIC ACID; 4 THIAZOLIDINONE DERIVATIVE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANILINOQUINAZOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BENZOPYRAN DERIVATIVE; CYCLOPEPTIDE; DISTAMYCIN A; DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER INHIBITOR; INDAZOLE DERIVATIVE; INDOLE DERIVATIVE; ISOXAZOLE DERIVATIVE; LEAD; MONASTROL; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER; OXINDOLE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE; PYRIMIDINE; QUINAZOLINE DERIVATIVE; RHODANINE; SOMATOSTATIN DERIVATIVE; SULFONAMIDE; TELEOCIDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; UREA DERIVATIVE; VANCOMYCIN;

CLINICAL TRIAL; COMBINATORIAL CHEMISTRY; COMBINATORIAL LIBRARY; DATA BASE; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; HUMAN; MOLECULAR MODEL; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

EID: 0035358567     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00203-9     Document Type: Review

References (77)

1. Standing on scale
2. High throughput screening of historic collections: Observations on file size, biological targets, and file diversity
3. Diversity screening versus focused screening in drug discovery
4. High throughput screening: New technology for the 21st century
5. Complementarity of combinatorial chemistry and structure-based ligand design: Application to the discovery of novel inhibitors of matrix metalloproteinases
6. Virtual screening speeds discovery
7. Simulated molecular evolution in a full combinatorial library
8. Comprehensive survey of combinatorial library synthesis: 1999
9. Inhibitors of strand transfer that prevents integration and inhibit HIV-1 replication in cells
10. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase
11. 4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells
12. 6 receptor antagonist
13. 6 antagonists: Identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)
14. Identification of a slow tight binding inhibitor of 3-deoxy-D-manno-octulosonic acid 8-phosphate synthase
15. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen
16. Dissecting cellular processes using small molecules: Identification of colchicines-like, taxol-like and other small molecules that perturb mitosis
17. Synthesis and preliminary evaluation of a library of polycyclic small molecules for use in chemical genetic assays
18. 2A antagonist
19. 2A receptor
20. 2A antagonists
21. Identification of a chemical tool for the orphan nuclear receptor FXR
22. 3,5-Bis(trifluoromethyl)pyrazoles: A novel class of NFAT transcription factor regulator
23. Novel antifungals based on 4-substituted imidazole: A combinatorial chemistry approach to lead discovery and optimization
24. Novel antifungals based on 4-substituted imidazole: Solid-phase synthesis of substituted aryl sulfonamides towards optimization of in vitro activity
25. Discovery of a new class of p38 kinase inhibitors
26. p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: Thienyl, furyl, and pyrrolyl ureas
27. CCR2B Receptor antagonists: Conversion of a weak HTS hit to a potent lead compound
28. The solid phase synthesis of tetrahydroisoquinolines having cdc25B inhibitory activity
29. 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2
30. Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors
31. 1,2-Dibenzamidobenzene inhibitors of human factor Xa
32. The synthesis and SAR of rhodanines as novel class C β-lactamase inhibitors
33. N-(sulfonamido)alkyl[tetrahydro-1H-benzo[e]indol-2-yl]amines: Potent antagonist of human neuropeptide Y Y5 receptor
34. Structure-activity relationships of a series of pyrrolo[3,2-d]pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists
35. Pyrrolidine inhibitors of human cytosolic phospholipase A2
36. Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)-propanoic acid (AMPA) receptors
37. Naphthyl ketones: A new class of Janus kinase 3 inhibitors
38. High-affinity, non-peptide agonists for the ORL1 (Orphanin FQ/Nociceptin) receptor
39. Discovery of novel p-arylthio cinnaimdes as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 1. Identification of an additional binding pocket based on an anilino diaryl sulfide lead
40. Synthesis of natural-product-based compounds libraries
41. Recent advances in solid-phase synthesis of natural products
42. Total synthesis of distamycin A and 2640 analogues: A solution-phase combinatorial approach to the discovery of new, bioactive DNA binding agents and development of a rapid, high-throughput screen for determining relative DNA binding affinity or DNA binding sequence selectivity
43. Solid-phase synthesis and biological evaluation of teleocidin library - Discovery of a selective PKCδ down regulator
44. Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans
45. Natural product-like combinatorial libraries based on privileged structures. 2. Construction of a 10 000-membered benzopyran library by direct split-and-pool chemistry using NanoKans and optical encoding
46. Natural product-like combinatorial libraries based on privileged structures. 3. The 'library from libraries' principle for diversity enhancement of benzopyran libraries
47. Target-accelerated combinatorial synthesis and discovery of highly potent antibiotics effective against vancomycin-resistant bacteria
48. Combinatorial library approach for the identification of synthetic receptors targeting vancomycin-resistant bacteria
49. Optimization of a somatostatin mimetic via constrained amino acid and backbone incorporation
50. Inhibition of BCRP-Mediated drug efflux by fumitremorgin-type indolyl diketopiperazines
51. Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity
52. Potent, orally active GPIIb/IIIa antagonists containing a nipecotic acid subunit. Structure-activity studies leading to the discovery of RWJ-53308
53. Rapid identification of subtype-selective agonist of the somatostatin receptor through combinatorial chemistry
54. A combinatorial approach toward the discovery of non-peptide subtype-selective somatostatin receptor ligands
55. Inhibitors of NF-κB and AP-1 gene expression: SAR studies on the pyrimidine portion of 2-chloro-4-trifluoromethylpyrimidine-5-[N-(3′,5′-bis (trifluoromethyl)-phenyl)carboxamide]
56. Designing small-molecule switches for protein-protein interaction
57. The discovery of potent cRaf1 kinase inhibitors
58. Discovery of carbohydrate sulfontransferase inhibitors from a kinase-directed library
59. Multistep solution-phase parallel synthesis of spiperone analogues
60. 4-Thiazolidinones: Novel inhibitors of the bacterial enzyme MurB
61. Identification of the new Cdc25 dual specificity phosphatase inhibitors in a small molecule array
62. Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazolines
63. Fenchylamine sulfonamide inhibition of amyloid β peptide production by the γ-secretase proteolytic pathway: Potential small-molecule therapeutic agents for the treatment of Alzheimer's disease
64. N-Acyl phenylalanine analogues as potent small molecule VLA-4 antagonsits
65. 2,4,5-Trisubstituted imidazoles: Novel nontoxic modulators of P-glycoprotein mediated multidrug resistance. Part 1
66. 2,4,5-Trisubstituted imidazoles: Novel nontoxic modulators of P-glycoprotein mediated multidrug resistance. Part 2
67. Virtual screening: An alternative or complement to high throughput screening
68. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations
69. Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads
70. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening
71. Structure-based discovery of small molecule inhibitors targeted to protein tyrosine phosphatase 1B
72. Discovery of a novel dopamine transporter inhibitor, 4-hydoxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone, as a potential cocaine antagonist through 3D-database pharmacophore searching. Molecular modeling, structure-activity relationships and behavioral pharmacological studies
73. Structure-based design and solid-phase parallel synthesis of phosphorylated nonpeptides to explore hydrophobic binding at the Src SH2 domain
74. Rational design of selective submicromolar inhibitors of Tritrichomonas foetus hypoxanthine-guanine-xanthine phosphoribosyltransferase
75. News in brief/miscellaneous-First HTS drug candidates reach clinical trials
76. Discovery of the potential antipsychotic PNU-177864, a selective dopamine D3 receptor antagonist, using high-throughput analoging techniques